Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Non Operating Income (2020 - 2025)

Rapid Micro Biosystems' Non Operating Income history spans 6 years, with the latest figure at -$272000.0 for Q4 2025.

  • On a quarterly basis, Non Operating Income fell 1195.24% to -$272000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$508000.0, a 177.44% decrease, with the full-year FY2025 number at $309000.0, up 375.89% from a year prior.
  • Non Operating Income hit -$272000.0 in Q4 2025 for Rapid Micro Biosystems, down from -$125000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for RPID hit a ceiling of $25.3 million in Q4 2021 and a floor of -$951000.0 in Q2 2021.
  • Historically, Non Operating Income has averaged $1.3 million across 5 years, with a median of -$21000.0 in 2022.
  • Biggest five-year swings in Non Operating Income: plummeted 4672.22% in 2021 and later soared 6300.0% in 2023.
  • Tracing RPID's Non Operating Income over 5 years: stood at $25.3 million in 2021, then plummeted by 100.04% to -$11000.0 in 2022, then plummeted by 54.55% to -$17000.0 in 2023, then dropped by 23.53% to -$21000.0 in 2024, then plummeted by 1195.24% to -$272000.0 in 2025.
  • Business Quant data shows Non Operating Income for RPID at -$272000.0 in Q4 2025, -$125000.0 in Q3 2025, and -$50000.0 in Q2 2025.